Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.0%

2 terminated out of 40 trials

Success Rate

90.5%

+4.0% vs benchmark

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

5%

1 of 19 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (22)
Early P 1 (1)
P 2 (9)
P 3 (1)
P 4 (2)

Trial Status

Completed19
Unknown5
Recruiting5
Active Not Recruiting4
Not Yet Recruiting4
Terminated2

Trial Success Rate

90.5%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (40)

Showing 20 of 20 trials
NCT06905587Phase 3Recruiting

Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue

NCT07529431Not ApplicableNot Yet RecruitingPrimary

Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors

NCT07498972Not ApplicableCompleted

Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer

NCT07445243Not ApplicableCompletedPrimary

Integrated Chinese and Western Therapy for Cancer-Related Fatigue

NCT07001241Phase 2RecruitingPrimary

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

NCT07337681Not ApplicableNot Yet Recruiting

Wearable Technology-Supported Exercise Program for Fatigue and Quality of Life in Pediatric Cancer Patients (WE-EX PedsCa)

NCT07159100Early Phase 1Not Yet RecruitingPrimary

tDCS for Cancer-Related Fatigue and Weakness

NCT05440227Phase 2RecruitingPrimary

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

NCT01720563Phase 2TerminatedPrimary

A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy

NCT01720550Phase 4CompletedPrimary

PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

NCT03314805Phase 2CompletedPrimary

PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy

NCT03611712Phase 2CompletedPrimary

PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

NCT05390398Not ApplicableCompleted

Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention

NCT04921644Active Not RecruitingPrimary

Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project)

NCT05448573Active Not RecruitingPrimary

A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening

NCT06782698Not ApplicableActive Not Recruiting

Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients

NCT03318224CompletedPrimary

Fatigue Prevalence, Severity, and State of Treatment in Germany

NCT06599710Not ApplicableRecruitingPrimary

The Effects of a Food Product Containing Mushroom Extracts (AndoSanTM) in Subjects with Colorectal Cancer-related Fatigue

NCT05891431Not ApplicableActive Not Recruiting

Engagement and Acceptability of the Untire mHealth App

NCT05454865Not ApplicableCompletedPrimary

The Effect of Jin Si Herbal Tea on Cancer-related Fatigue of Gynecological Cancer Patients

Scroll to load more

Research Network

Activity Timeline